These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17419254)

  • 1. Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.
    Arai I; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Sugita Y; Ota H; Yoshioka S; Nakamura M; Wada H; Damdinsuren B; Kato H; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshita K; Nakamori S; Wakasa K; Sakon M; Monden M
    Hepatogastroenterology; 2007; 54(73):167-71. PubMed ID: 17419254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential.
    Arii S; Mise M; Harada T; Furutani M; Ishigami S; Niwano M; Mizumoto M; Fukumoto M; Imamura M
    Hepatology; 1996 Aug; 24(2):316-22. PubMed ID: 8690399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma.
    Ishii Y; Nakasato Y; Kobayashi S; Yamazaki Y; Aoki T
    J Exp Clin Cancer Res; 2003 Sep; 22(3):461-70. PubMed ID: 14582707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
    Zhao WB; Li Y; Liu X; Zhang LY; Wang X
    Int J Mol Med; 2008 Aug; 22(2):187-92. PubMed ID: 18636172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues.
    Ogasawara S; Yano H; Momosaki S; Nishida N; Takemoto Y; Kojiro S; Kojiro M
    Oncol Rep; 2005 Jun; 13(6):1043-8. PubMed ID: 15870919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
    Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; Kiliç M
    Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical localization of membrane type 1-matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma.
    Ip YC; Cheung ST; Fan ST
    Mol Carcinog; 2007 Mar; 46(3):225-30. PubMed ID: 17219425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of heat shock protein 27 expression in hepatocellular carcinoma in Japan: special reference to the difference between hepatitis B and C.
    Harimoto N; Shimada M; Aishima S; Kitagawa D; Itoh S; Tsujita E; Maehara S; Taketomi A; Tanaka S; Shirabe K; Maehara Y
    Liver Int; 2004 Aug; 24(4):316-21. PubMed ID: 15287854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of angiogenesis in hepatitis and hepatocellular carcinoma.
    Ker CG; Chen HY; Juan CC; Lo HW; Shen YY; Chen JS; Lee KT; Sheen PC
    Hepatogastroenterology; 1999; 46(26):646-50. PubMed ID: 10370590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of interferon alpha/beta receptor in human hepatocellular carcinoma.
    Kondo M; Nagano H; Sakon M; Yamamoto H; Morimoto O; Arai I; Miyamoto A; Eguchi H; Dono K; Nakamori S; Umeshita K; Wakasa K; Ohmoto Y; Monden M
    Int J Oncol; 2000 Jul; 17(1):83-8. PubMed ID: 10853022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M; Kotsafti A; Cardin R; Farinati F
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
    Chung TW; Kim JR; Suh JI; Lee YC; Chang YC; Chung TH; Kim CH
    J Gastroenterol Hepatol; 2004 May; 19(5):565-71. PubMed ID: 15086601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
    Damdinsuren B; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Yamamoto T; Marubashi S; Miyamoto A; Umeshita K; Dono K; Nakamori S; Wakasa K; Sakon M; Monden M
    Int J Oncol; 2005 Feb; 26(2):319-27. PubMed ID: 15645115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of membrane-type 1 matrix metalloproteinase in the invasion and metastasis of hepatocellular carcinoma].
    Cai Y; Wu Z; Fan J; Feng G; He B; Liu Y; Ye S; Tang Z
    Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):236-8. PubMed ID: 10951628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y; Koda M; Murawaki Y
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma.
    Xie H; Song J; Du R; Liu K; Wang J; Tang H; Bai F; Liang J; Lin T; Liu J; Fan D
    Dig Liver Dis; 2007 Feb; 39(2):167-72. PubMed ID: 17161983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas.
    Nakatsukasa H; Ashida K; Higashi T; Ohguchi S; Tsuboi S; Hino N; Nouso K; Urabe Y; Kinugasa N; Yoshida K; Uematsu S; Ishizaki M; Kobayashi Y; Tsuji T
    Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor and matrix metalloproteinase-2 correlates with the invasion and metastasis of hepatocellular carcinoma.
    Liu Z; Yan L; Xiang T; Jiang L; Yang B
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):249-50, 254. PubMed ID: 12856590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.